Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Sci-Tech Network.
Press releases published on September 5, 2025

DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq
Châtillon, France, September 5, 2025 DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Capital Market: DBVT) (the “Company”), a clinical-stage biopharmaceutical company, …

DBV Technologies met en place un Programme At-The-Market (ATM) sur le Nasdaq
Châtillon, France, le 5 septembre (22:30 CEST) 2025 DBV Technologies met en place un Programme At-The-Market (ATM) sur le Nasdaq DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Capital Market : DBVT) (la « Société »), une société …

DIH Holding US, Inc. Receives Nasdaq Staff Determination Letter
DIH Receives Notice for Continued Deficiency and Delist Letter from the Nasdaq Stock Market DIH Intends to Request Hearing to Appeal in a Timely Manner NORWELL, Mass., Sept. 05, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. (“DIH” or the “Company”) (NASDAQ …

dLocal Announces Closing of Secondary Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
MONTEVIDEO, Uruguay, Sept. 05, 2025 (GLOBE NEWSWIRE) -- DLocal Limited (“dLocal”), (NASDAQ:DLO) a technology-first payments platform, today announced the closing of a previously announced secondary offering of 17,250,000 Class A common shares (including 2, …

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and …

Rapport Therapeutics to Announce Topline Results for RAP-219 Phase 2a Trial in Focal Onset Seizures on Monday, September 8, 2025
BOSTON and SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for …

Artelo Biosciences Announces Closing of $3.0 Million Public Offering
SOLANA BEACH, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic …

Gyre Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, today …

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
NEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on September 1, 2025 the Company granted inducement awards to …

Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
REDWOOD CITY, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum’s Board of Directors granted inducement awards consisting of non-qualified stock options to …

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or “the Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase …

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WESTLAKE VILLAGE, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an …

DIAGNOS Announces Closing of Private Placement
BROSSARD, Quebec, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues using advanced technology based on Artificial …

“Witness the Revolution”: GIRAFFEVISION Unveils a New Era of Mobility at IAA
BADEN-WÜRTTEMBERG, Germany, Sept. 05, 2025 (GLOBE NEWSWIRE) -- From September 8 to 12, 2025, the global mobility industry will once again turn its eyes to Munich. On this world-class stage for smart mobility innovation, GIRAFFEVISION—a pioneer redefining …

Mevryon Platform: Why Mevryon Platform Is Becoming the Core of AI-Based Trading in 2025
New York City, NY, Sept. 05, 2025 (GLOBE NEWSWIRE) -- What Is Mevryon Platform? Introduction to AI-Powered Trading in 2025 The Mevryon Platform represents a forward step in the evolution of digital finance, delivering an infrastructure that integrates …

Web3 Ghostwriter Fly You Fools Named 2025 Great British Entrepreneur Awards Finalist
London, UK, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Fly You Fools, the Web3 ghostwriting and content strategy agency, has been named a finalist for Start-Up Entrepreneur of the Year (South East) at the 2025 Allica Bank Great British Entrepreneur Awards. The …

Bristol Bay Cellular et RINA lancent le réseau central basé sur le cloud de l’Alaska, optimisé par Mavenir
RICHARDSON, Texas, 05 sept. 2025 (GLOBE NEWSWIRE) -- Mavenir, le fournisseur d’infrastructures réseau basées sur le cloud, a annoncé aujourd’hui une expansion significative de ses solutions Packet et Voice Core cloud-native en Alaska, grâce à des accords …

브리스톨 베이 셀룰러 (Bristol Bay Cellular)와 RINA, Mavenir 솔루션에 기반한 알래스카 지역의 클라우드 네이티브 코어 네트워크 구축
텍사스주 리처드슨, Sept. 06, 2025 (GLOBE NEWSWIRE) -- 클라우드 네이티브 네트워크 인프라 제공기업인 Mavenir는 브리스톨 베이 셀룰러 (Bristol Bay Cellular) 및 RINA (Rural Independent Network Alliance) 와의 협약을 통해 알래스카에서 클라우드 네이티브 패킷 및 보이스 코어 솔루션을 대폭 확장한다고 오늘 발표했다. 알래스카 지역에서의 완전 클라우드 네이티브 모바일 코어 구축은 …

Bristol Bay Cellular dan RINA akan Melancarkan Rangkaian Teras Awan Natif Alaska yang Dikuasakan oleh Mavenir
RICHARDSON, Texas, Sept. 06, 2025 (GLOBE NEWSWIRE) -- Mavenir, penyedia infrastruktur rangkaian berasaskan awan, hari ini mengumumkan pengembangan besar bagi penyelesaian Packet dan Voice Core berasaskan awan mereka ke Alaska melalui perjanjian dengan …